Understand the side effects, the expected timeline, and the dietary adjustments that optimize results
In recent years, interest has grown around using a GLP-1 for PCOS particularly semaglutide as part of a comprehensive treatment plan
Human Error & Handling Risks Common failures include leaving GLP-1 stock at room temperature during transfers or storing it in domestic fridges
examined the effectiveness of a Japanese oral supplement containing collagen peptides on skin hydration and the natural moisturizing factor content in 99 healthy Japanese women, aged 3550 years, who were divided into three groups (33 subjects/group) and received 1 or 5 g of collagen peptides or placebo once daily for 12 weeks [38]
"This is not a replacement for trials, but it can move much faster, and that speed matters when a drug goes from niche to mainstream almost overnight." When it came to potential side effects that doctors may not know about, two groups of complaints stood out: reproductive health issues (including irregular menstrual cycles) and temperature-related problems (such as chills and hot flashes)
Here are the average weight loss results based on the dose and timeline: 1 mg: 7.2% in 24 weeks and 8.7% in 48 weeks 4 mg: 12.9% in 24 weeks and 16.3% in 48 weeks 8 mg: 17.3% in 24 weeks and 23.9% in 48 weeks 12 mg: 17.5% in 24 weeks and 24.2% in 48 weeks Placebo: 1.6% in 24 weeks and 2.1% in 48 weeks The retatrutide clinical trials are still ongoing, with a phase IV planned after the current phase III